Hudson Technologies is a small-cap refrigerant reclamation company riding a slow-moving but near-guaranteed regulatory tailwind. The stock trades under $6, well off its 2024 highs. It also carries real near-term margin pressure.
This report breaks down the business, the growth drivers, who this stock actually suits, and what Wall Street thinks — without the recycled boilerplate most coverage repeats.
Data current as of August 18, 2026.
Company Snapshot
| Metric | Detail |
|---|---|
| Ticker | NASDAQ: HDSN |
| Sector | Industrials — Refrigerant Reclamation & Distribution |
| Founded | 1991, Woodcliff Lake, NJ |
| Recent price | ~$5.67 – $5.80 |
| Market cap | ~$239 million (micro-cap) |
| 52-week range | $4.64 – $10.52 |
| Dividend | None |
| Trailing P/E | ~27x |
| Cash on hand | $25.6 million, no debt |
HDSN sits firmly in micro-cap territory. That single fact should shape how any investor approaches this stock. More on that below.
What Hudson Technologies Actually Does
Hudson does not manufacture refrigerant. It recovers, reclaims, and resells it. Old refrigerant gets pulled out of commercial AC units, industrial systems, and cold storage equipment. Hudson cleans it, tests it in its own lab, and resells it as certified “EMERALD Refrigerants.”
Three business lines
- Refrigerant and industrial gas sales — the core revenue driver, tied to spot HFC pricing.
- Refrigerant management services — reclamation, lab testing, and banking/storage.
- RefrigerantSide Services — on-site system decontamination for large commercial and industrial clients.
A government contractor too
Hudson has served as prime contractor to the U.S. Defense Logistics Agency since 2016. That relationship just got a lot more important. More on this in the catalysts section.
Q2 FY2026 Earnings
Hudson reported second-quarter 2026 results on August 5, 2026. The print tells a two-sided story: strong demand, weak pricing.
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $78.3M | $72.4M | +8% |
| Sales volume | — | — | +12% |
| Avg. refrigerant price | — | — | -6% |
| Gross margin | 26% | 31% | -500 bps |
| Net income | $4.9M | $10.2M | -52% |
| Diluted EPS | $0.12 | $0.23 | -48% |
| Cash (no debt) | $25.6M | — | — |
Volume did the heavy lifting. Pricing did not cooperate. HFC prices sat near a multi-year trough for most of the quarter, and management pushed full-year 2026 gross margin guidance down from “mid-20s%” to “low-to-mid-20s%.” A tornado also hit an Illinois facility in mid-June. Operations were restored quickly, and insurance is expected to cover the costs.
Investor Prem Watsa Portfolio Analysis. https://dailystocks7.com/2026/08/22/prem-watsa-fairfax-financial-portfolio-analysis/
Q1 2026 followed a similar pattern: revenue up 9% to $60.2 million, sales volume up 20%, but gross margin fell to 20% from 22%, and EPS came in at less than a cent versus $0.063 a year earlier.
The pattern to notice: demand keeps climbing double digits. Revenue and earnings keep lagging behind it. That gap is the whole HDSN story right now.
The Core Investment Thesis: The AIM Act Phasedown
This is the reason HDSN exists as an investable idea at all.
The American Innovation and Manufacturing (AIM) Act requires U.S. producers to cut virgin HFC refrigerant production and consumption down to 15% of historic baseline levels by 2036, in line with the Kigali Amendment to the Montreal Protocol. New EPA rules keep tightening the screws:
- A mandatory leak detection and repair rule took effect January 1, 2026 for equipment holding 15+ pounds of HFC refrigerant.
- A finalized Technology Transitions rule took effect July 27, 2026, restricting which HFCs can be used in new equipment by sector.
Why this favors a reclaimer over a producer
Millions of existing AC and refrigeration systems still run on legacy HFCs. Virgin supply keeps shrinking under the allowance system. Reclaimed refrigerant is exempt from that allowance cap. That combination — falling legal supply, fixed installed base, exempt reclaimed volume — is a structural setup that favors companies like Hudson over the next decade. HFO-compatible equipment is not expected to be widely available for another two to three years, which stretches out the runway for legacy refrigerant reclamation even further.
10 Aerospace and Defence Stocks in India Analysis. https://dailystocks7.com/2026/08/20/10-aerospace-defence-stocks-in-india-a-complete-2026-investor-guide/
This is a regulatory tailwind, not a demand-creation story. Hudson does not need to convince anyone to buy its product. The law does that work.
Future Growth Potential and Catalysts
1. The $210 million DLA contract, restored
Hudson won a prime IDIQ contract with the Defense Logistics Agency in October 2025. A rival bidder filed a protest with the U.S. Court of Federal Claims in January 2026, and the award was rescinded pending a rebid. On August 5, 2026, the DLA re-awarded the contract to Hudson. Terms run through August 4, 2031, worth $210 million, with a five-year DLA option to extend to 2036.
This removes a real overhang that had been sitting on the stock since January. It also confirms Hudson’s decade-long relationship with the DLA survived a competitive re-bid.
2. The Icorium partnership
In July 2026, Hudson signed a preliminary agreement with Icorium, a Kansas-based startup, to commercialize a patented extractive distillation technology. The pitch: it separates complex, contaminated HFC/HFO blends that conventional fractional distillation struggles with, turning more recovered refrigerant into saleable product. If it scales, this directly improves reclamation yield and margin — the exact metric that’s been under pressure all year.
Best 25 Construction Stocks in India Full Analysis . https://dailystocks7.com/2026/08/19/indias-top-25-construction-stocks-full-analysis/
3. Small Recovery Truck (SRT) pilot
Hudson piloted small recovery trucks in New York City to capture refrigerant from high-density, lower-volume sites that traditional recovery methods miss. Management confirmed the pilot is already revenue-positive and plans to expand it to other major metro areas. This widens Hudson’s feedstock funnel — the raw material for its entire reclamation business.
4. Positioning for the HFO transition
Hudson holds licensing agreements to reclaim R-448A and R-449A, next-generation HFO blends. Volume traction is still early, but it puts Hudson ahead of the curve as HFOs slowly displace HFCs in new equipment over the coming years.
5. Balance sheet optionality
No debt, $25.6 million in cash, and an active opportunistic buyback program ($2.5 million repurchased in Q1 2026 alone). Management has flagged appetite for further M&A in adjacent reclamation and services niches.
Who Should Consider This Stock
| Fits well for | Not a fit for |
|---|---|
| Investors comfortable with micro-cap volatility | Income investors — no dividend |
| Multi-year thematic investors betting on the AIM Act phasedown through 2036 | Anyone needing earnings stability quarter to quarter |
| Investors who already understand commodity-price-driven margin swings | Investors relying on short-term price-target apps for entry timing |
| Portfolio diversifiers looking for an environmental-regulation angle outside solar/EV | Risk-averse investors who need consistent free cash flow |
HDSN is not a “buy and forget” story. Refrigerant pricing swings quarter to quarter, and Hudson’s own margins swing with it. The regulatory tailwind is real and long-dated, but the stock price reacts to next quarter’s HFC spot price far more than to a rule that fully plays out by 2036.
Risk Factors: The Bear Case
- Commodity price exposure. Hudson doesn’t set HFC prices. A trough in spot pricing, as seen through most of 2026, compresses margin even when volume grows.
- Negative free cash flow. Trailing twelve-month levered free cash flow sits around -$38.7 million, driven by inventory build and working capital needs, despite the company being GAAP-profitable. Profitable on paper and cash-generative are not the same thing here.
- Guidance cuts. Full-year gross margin guidance has been trimmed twice in 2026 alone.
- Contract concentration and litigation risk. The DLA award was disputed once already this year. Government contract dependency carries recurring rebid and protest risk.
- Thin liquidity. As a micro-cap, HDSN trades on lower volume than large-cap peers, which can mean wider price swings on modest news flow.
- Earnings quality flags. Independent research has flagged an elevated accrual ratio, a signal worth watching for anyone underwriting the earnings numbers at face value.
Expert Opinions on HDSN
Coverage is thin — only two to five analysts actively track this name, so any “consensus” should be read with that caveat.
| Firm | Date | Rating | Price Target |
|---|---|---|---|
| Canaccord Genuity | Aug 6, 2026 | Buy (maintained) | $8.00 (cut from $9.00) |
| B. Riley | Aug 6, 2026 | Buy (maintained) | $7.25 (cut from $8.00) |
| S&P Global consensus (4 analysts) | Aug 2026 | Buy | ~$8.50 average |
| Broader Wall Street mix | Aug 2026 | Buy/Hold split | $7.00 – $9.00 range |
Both analysts still covering the name kept Buy ratings even as they trimmed targets after Q2 — the cuts reflect near-term margin caution, not a change in long-term thesis. Canaccord’s note specifically pointed to the Icorium partnership and ERP-driven efficiency as reasons to stay constructive despite the pricing headwinds.
India’s Industrial Decade, Best Stocks to Invest? https://dailystocks7.com/2026/08/18/indias-industrial-decade-which-sectors-will-deliver-china-style-returns/
Not everyone agrees. Independent equity research from StockStory has taken a skeptical, non-consensus stance on Hudson, citing softening near-term sales growth estimates and balance sheet strain that could eventually force dilutive financing if cash tightens. That’s a useful counterweight — most retail-facing coverage on this stock just repeats the sell-side Buy rating without noting anyone disagrees.
Unique Insights You Won’t Find on Most Stock Sites
1. Watch the volume-versus-revenue gap, not just the headline growth number. Sales volume has grown in the double digits for multiple consecutive quarters (12% in Q2, 20% in Q1). Revenue growth has come in far lower, at 8% and 9% respectively. The gap is pure pricing drag. Most coverage reports “revenue up 8%” as the headline and buries the volume figure. The volume number is the better proxy for whether the AIM Act thesis is actually playing out on the ground.
Best Solar Panel manufacturing Stocks in India . https://dailystocks7.com/2026/08/17/solar-panel-manufacturing-stocks-india-aluminium-wires-solar-glass/
2. Be skeptical of algorithmic price-prediction sites. Several automated forecasting tools currently show absurd short-term upside for HDSN — one shows a 30-day target implying over 300% gains. These are algorithmic extrapolations, not analyst research, and they conflict wildly with actual sell-side targets sitting in the $7–$9 range. Treat any HDSN price target quoting triple-digit percentage upside within weeks as noise, not signal.
3. The reclaimer-versus-producer distinction matters more than people realize. Chemours and Solstice Advanced Materials (the Honeywell refrigerants spinoff) are virgin HFC/HFO producers, both multi-billion-dollar companies with diversified chemical portfolios. Hudson is a pure-play reclaimer, a fundamentally different position in the same regulatory story. Producers face shrinking allowances. Reclaimers face growing demand for allowance-exempt product. Comparing HDSN directly to CC or SOLS on valuation multiples, as some screeners do, misreads the business model.
Tech vs Value Stocks Full Analysis . https://dailystocks7.com/2026/08/15/tech-stocks-vs-value-stocks-in-usa/
| Company | Market cap (approx.) | Role in refrigerant market |
|---|---|---|
| Hudson Technologies (HDSN) | ~$0.24B | Pure-play reclaimer, micro-cap |
| Chemours (CC) | ~$3.3B | Virgin HFC/HFO producer, diversified |
| Solstice Advanced Materials (SOLS) | ~$9.7B | Virgin HFO producer, diversified materials |
4. Free cash flow, not net income, is the number to track next. Hudson has been consistently profitable on a GAAP basis, but negative levered free cash flow means the balance sheet strength (no debt, $25.6M cash) is doing more work than the income statement suggests. If reclaimed volume keeps outrunning cash conversion, that gap becomes the story to watch heading into 2027 guidance.
Disclaimer:
This article is for informational and educational purposes only and does not constitute investment advice. Stock market investments, including in US-listed equities, carry risk of loss. Data is sourced from company filings, earnings releases, and third-party analyst coverage as of the date noted above and is subject to change.
Leave a Reply